NCT06159140

Small Vessel Diseases: Ultra-realistic Microstructure Computational Model to Refine Individual Treatment

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: University Hospital, Tours · Academic / Other
• Sex: All
• Age: 82 Years – 100 Years
• Healthy volunteers: Accepted

Summary

Small vessel disease (SVD) accounts for 25% of strokes and is the second most common cause of dementia after Alzheimer's disease. Unlike other causes of stroke, SVD manifests itself years before the stroke by the accumulation of tissue damage. Although heterogeneous, these lesions appear on Magnetic Resonance Imaging (MRI) as white matter hypersignals (WMH). In this context, the ANR SUMMIT project will characterize these lesions in vivo to develop new markers in the early stages of stroke. It is subdivided into 4 work packages, the third one being promoted by CHRU de Tours.

Conditions

• Small Vessel Disease

Interventions

Type	Name	Description
DEVICE	MRI	In vivo MRI

Timeline

• Start date: 2024-03-26
• Primary completion: 2026-03-01
• Completion: 2026-03-01
• First posted: 2023-12-06
• Last updated: 2024-05-23

Locations

1 site across 1 country: France